Download Our DHN Survey Result 2024
Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

IIT Indore Study Reveals AI Model Can Detect Alzheimer’s Early

Written by : Arti Ghargi

May 7, 2024

Category Img

Image Source: Freepik

The study's findings highlight the potential of AI in transforming healthcare diagnostics and addressing complex medical challenges.

Artificial Intelligence (AI) has the potential to diagnose Alzheimer's disease at an early stage, a recent study published by IIT Indore researchers has shown.

The study has been published in the esteemed Nature Mental Health journal in which the research introduces a computer-based diagnostic approach that works alongside medical specialists to accurately identify Alzheimer's.

The study named ‘Ensemble Deep Learning for Alzheimer’s Disease (AD) Characterisation and Estimation’ led by Professor M Tanveer, emphasizes the significance of timely and precise diagnosis in managing Alzheimer's disease.

The research was conducted in collaboration with institutions worldwide, including the University of Manitoba, Canada, TECNALIA, Spain, Qatar University, and the University of Technology Sydney, Australia to bring together multidisciplinary expertise to advance Alzheimer's diagnosis and management.

"Accurate and early diagnosis of Alzheimer's disease is paramount for effective intervention and treatment planning," Professor Tanveer said.

Ensemble Deep Learning Model Help in Alzheimer's Detection

The study's findings highlight the potential of AI in transforming healthcare diagnostics and addressing complex medical challenges.

The study delves into sophisticated design features, diversity, and the combination of different types of data, including neuroimaging and genetic information.

The researchers have developed models capable of identifying structural and functional changes in the brain associated with Alzheimer's by leveraging ensemble deep learning, an advanced AI technique.

By integrating neuroimaging data from techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET), the researchers have refined ensemble deep learning models for accurate diagnosis.

"Our research not only enhances diagnostic precision but also enriches our understanding of Alzheimer's dynamics," Prof Tanveer said.

He underscored that early diagnosis of Alzheimer’s allows for timely intervention, better management of the condition, and helps in planning appropriate treatments.

“Moreover, understanding the brain's dynamics through advanced AI techniques can significantly enhance the quality of life for patients and their families," he added.

AI in Alzheimer Detection

As the global population ages, the burden of Alzheimer's disease continues to grow. According to the data analyzed from 1990 to 2019, the incidence of Alzheimer's disease and other dementias rose by 147.95%, with 2.92 million cases in 1990 and 7.24 million cases in 2019 globally.

However, Artificial Intelligence (AI) is providing a ray of hope in the field of Alzheimer's disease detection by offering advanced tools for early diagnosis and intervention.

Through the analysis of brain MRI data, AI models developed by researchers at institutions such as Massachusetts General Hospital have reportedly shown remarkable accuracy in identifying Alzheimer's risk factors, achieving detection rates as high as 90.2% across diverse datasets.

These AI algorithms can detect subtle patterns and changes in brain structure that may indicate the presence of Alzheimer's, enabling healthcare professionals to intervene at earlier stages of the disease.

Moreover, AI's application extends to retinal imaging, where deep learning algorithms can analyze retinal photographs to detect signs of Alzheimer's disease with promising accuracy.

This approach offers a non-invasive and potentially scalable method for screening individuals for Alzheimer's risk, paving the way for population-level detection and timely interventions.

By leveraging AI in conjunction with metabolic biomarkers, as demonstrated by researchers at West Virginia University, it becomes possible to predict Alzheimer's diagnosis based on specific metabolic signatures associated with the disease, providing a more comprehensive and personalized approach to detection and monitoring.

About Chime India

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024